$WKHS
Workhorse Group Inc. Stock $wkhs

$wkhs Overview Financials Valuation SEC Filings Company Website

2020 Form 10-K Financial Statement

#000162828021003538 Filed on March 01, 2021

Income Statement

Concept	2020	2019 Q4	2019
Revenue	$1.393M	$0.00	$376.6K
YoY Change	269.8%	-100.0%	-50.66%
Cost Of Revenue	$13.07M	$2.090M	$5.845M
YoY Change	123.56%	-81.19%	-26.77%
Gross Profit	-$11.67M	-$2.090M	-$5.468M
YoY Change	113.49%	-81.15%	-64.0%
Gross Profit Margin	-838.38%		-1452.17%
Selling, General & Admin	$20.16M	$3.560M	$10.20M
YoY Change	97.63%	30.88%	-11.2%
% of Gross Profit
Research & Development	$9.149M	$3.980M	$8.199M
YoY Change	11.58%	132.75%	10.92%
% of Gross Profit
Depreciation & Amortization	$809.6K	$100.0K	$388.4K
YoY Change	108.46%	0.0%	11.5%
% of Gross Profit
Operating Expenses	$29.31M	$7.540M	$18.40M
YoY Change	59.29%	70.2%	-2.54%
Operating Profit	-$40.98M	-$9.630M	-$23.87M
YoY Change	71.71%	-37.95%	-29.94%
Interest Expense	$190.5M	-$5.560M	$29.15M
YoY Change	553.68%	155.05%	1097.07%
% of Operating Profit
Other Income/Expense, Net	$322.8M	$15.85M	$15.85M
YoY Change	1936.34%
Pretax Income	$91.61M	$660.0K	-$37.16M
YoY Change	-346.51%	-103.73%	1.81%
Income Tax	$21.83M		$0.00
% Of Pretax Income	23.83%
Net Earnings	$69.78M	$660.0K	-$37.16M
YoY Change	-287.76%	-103.73%	1.81%
Net Earnings / Revenue	5010.81%		-9868.98%
Basic Earnings Per Share	$0.75		-$0.58
Diluted Earnings Per Share	$0.70	$9.916K	-$0.58
COMMON SHARES
Basic Shares Outstanding	92.87M shares	66.86M shares	64.31M shares
Diluted Shares Outstanding	99.95M shares		64.31M shares

Balance Sheet

Concept	2020	2019 Q4	2019
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.80M	$23.90M	$23.90M
YoY Change	95.82%	1493.33%	1493.33%
Cash & Equivalents	$46.80M	$23.87M	$23.90M
Short-Term Investments
Other Short-Term Assets	$227.2M	$5.800M	$5.800M
YoY Change	3817.24%	152.17%	152.17%
Inventory	$15.50M	$1.798M	$1.800M
Prepaid Expenses
Receivables	$900.0K	$7.921K	$0.00
Other Receivables	$100.0K	$0.00	$0.00
Total Short-Term Assets	$290.5M	$31.52M	$31.50M
YoY Change	822.22%	394.87%	392.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.40M	$6.830M	$6.800M
YoY Change	67.65%	30.41%	30.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$330.6M	$12.20M	$12.20M
YoY Change	2609.84%
Other Assets
YoY Change
Total Long-Term Assets	$342.0M	$19.15M	$19.20M
YoY Change	1681.25%	252.39%	255.56%
TOTAL ASSETS
Total Short-Term Assets	$290.5M	$31.52M	$31.50M
Total Long-Term Assets	$342.0M	$19.15M	$19.20M
Total Assets	$632.5M	$50.67M	$50.70M
YoY Change	1147.53%	329.27%	329.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.800M	$1.679M	$1.700M
YoY Change	182.35%	-61.32%	-60.47%
Accrued Expenses	$6.000M	$3.408M	$3.100M
YoY Change	93.55%	-13.64%	-20.51%
Deferred Revenue		$303.0K
YoY Change		-25.37%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due	$1.400M	$0.00	$19.60M
YoY Change	-92.86%
Total Short-Term Liabilities	$17.60M	$47.04M	$47.00M
YoY Change	-62.55%	148.71%	148.68%
LONG-TERM LIABILITIES
Long-Term Debt	$197.7M	$0.00	$38.50M
YoY Change	413.51%	-100.0%	363.86%
Other Long-Term Liabilities	$200.0K	$0.00
YoY Change
Total Long-Term Liabilities	$197.9M	$0.00	$38.50M
YoY Change	414.03%	-100.0%	363.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$17.60M	$47.04M	$47.00M
Total Long-Term Liabilities	$197.9M	$0.00	$38.50M
Total Liabilities	$237.3M	$85.59M	$85.60M
YoY Change	177.22%	214.34%	214.71%
SHAREHOLDERS EQUITY
Retained Earnings		-$178.8M
YoY Change		26.31%
Common Stock		$67.11K
YoY Change		15.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$395.2M	-$34.91M	-$34.90M
YoY Change
Total Liabilities & Shareholders Equity	$632.5M	$50.67M	$50.70M
YoY Change	1147.53%	329.27%	329.66%

Cashflow Statement

Concept	2020	2019 Q4	2019
OPERATING ACTIVITIES
Net Income	$69.78M	$660.0K	-$37.16M
YoY Change	-287.76%	-103.73%	1.81%
Depreciation, Depletion And Amortization	$809.6K	$100.0K	$388.4K
YoY Change	108.46%	0.0%	11.5%
Cash From Operating Activities	-$70.28M	-$12.73M	-$36.87M
YoY Change	90.6%	188.01%	69.49%
INVESTING ACTIVITIES
Capital Expenditures	$5.728M	$1.990M	$2.000M
YoY Change	186.34%	1709.09%	8514.67%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$3.650M	$3.660M
YoY Change	-100.0%
Cash From Investing Activities	-$5.728M	$5.650M	$1.655M
YoY Change	-446.21%	5036.36%	-9081.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00		$5.928M
YoY Change	-100.0%
Debt Paid & Issued, Net	$0.00		$10.00M
YoY Change	-100.0%		1.1%
Cash From Financing Activities	$292.4M	21.79M	$58.57M
YoY Change	399.15%	667.25%	204.82%
NET CHANGE
Cash From Operating Activities	-$70.28M	-12.73M	-$36.87M
Cash From Investing Activities	-$5.728M	5.650M	$1.655M
Cash From Financing Activities	$292.4M	21.79M	$58.57M
Net Change In Cash	$216.4M	14.71M	$23.36M
YoY Change	826.37%	-1100.68%	-1013.5%
FREE CASH FLOW
Cash From Operating Activities	-$70.28M	-$12.73M	-$36.87M
Capital Expenditures	$5.728M	$1.990M	$2.000M
Free Cash Flow	-$76.01M	-$14.72M	-$38.87M
YoY Change	95.53%	224.94%	78.5%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001425287
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Annual Report DocumentAnnualReport	true
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Transition Report DocumentTransitionReport	false
CY2020	dei	Entity File Number EntityFileNumber	001-37673
CY2020	dei	Entity Registrant Name EntityRegistrantName	WORKHORSE GROUP INC.
CY2020	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2020	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1394771
CY2020	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 Commerce Drive
CY2020	dei	Entity Address City Or Town EntityAddressCityOrTown	Loveland
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2020	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	45140
CY2020	dei	City Area Code CityAreaCode	513
CY2020	dei	Local Phone Number LocalPhoneNumber	360-4704
CY2020	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2020	dei	Trading Symbol TradingSymbol	WKHS
CY2020	dei	Trading Symbol TradingSymbol	WKHS
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2020	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Public Float EntityPublicFloat	1129851463	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	123506483	shares
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46817825	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46817825	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23868416	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	194411242	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1000000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	884367	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7921	USD
CY2020Q4	wkhs	Finance Lease Receivable Current FinanceLeaseReceivableCurrent	153099	USD
CY2019Q4	wkhs	Finance Lease Receivable Current FinanceLeaseReceivableCurrent	33100	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	15467012	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1798146	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32759216	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4812088	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	290492761	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	31519671	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11398166	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6830181	USD
CY2020Q4	wkhs	Finance Lease Receivable Noncurrent FinanceLeaseReceivableNoncurrent	94698	USD
CY2019Q4	wkhs	Finance Lease Receivable Noncurrent FinanceLeaseReceivableNoncurrent	129177	USD
CY2020Q4	us-gaap	Assets Assets	632542369	USD
CY2019Q4	us-gaap	Assets Assets	50673829	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4790763	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1678983	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5995302	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3408184	USD
CY2020Q4	wkhs	Warranty Liability WarrantyLiability	5400000	USD
CY2019Q4	wkhs	Warranty Liability WarrantyLiability	6001864	USD
CY2020Q4	wkhs	Convertible Debt Current Maturities At Fair Value ConvertibleDebtCurrentMaturitiesAtFairValue	0	USD
CY2019Q4	wkhs	Convertible Debt Current Maturities At Fair Value ConvertibleDebtCurrentMaturitiesAtFairValue	19620000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1411000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17597065	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	47044031	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	197700000	USD
CY2019Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	19400000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	207040	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	21833930	USD
CY2020Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent	0	USD
CY2019Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent	19142908	USD
CY2020Q4	us-gaap	Liabilities Liabilities	237338035	USD
CY2019Q4	us-gaap	Liabilities Liabilities	85586939	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	75000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	75000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	121922532	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	121922532	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67105000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67105000	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	121923	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	67105	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	504112442	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	143826315	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109030031	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178806530	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	395204334	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-34913110	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	632542369	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	50673829	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1392519	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	376562	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	13067108	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	5844891	USD
CY2020	us-gaap	Gross Profit GrossProfit	-11674589	USD
CY2019	us-gaap	Gross Profit GrossProfit	-5468329	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20157658	USD
CY2019	wkhs	Preferred Stock Dividends Common Stock Issued Value PreferredStockDividendsCommonStockIssuedValue	1166771	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10199534	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9148931	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8199074	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	29306589	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	18398608	USD
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	323111944	USD
CY2019	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	15849800	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	282130766	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-8017137	USD
CY2020	us-gaap	Interest Expense InterestExpense	190520337	USD
CY2019	us-gaap	Interest Expense InterestExpense	29145690	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	91610429	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37162827	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21833930	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	69776499	USD
CY2019	wkhs	Value Of Warrants Issued With Convertible Notes ValueOfWarrantsIssuedWithConvertibleNotes	430000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-37162827	USD
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.58
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.58
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92871936	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92871936	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64314756	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99949868	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64314756	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-15422443	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5928235	USD
CY2019	wkhs	Stock Options And Warrants Exercised And Vesting Of Restricted Shares StockOptionsAndWarrantsExercisedAndVestingOfRestrictedShares	35306	USD
CY2019	wkhs	Adjustment To Additional Paid In Capital Warrant Reclassification AdjustmentToAdditionalPaidInCapitalWarrantReclassification	857072	USD
CY2019	wkhs	Deemed Dividend DeemedDividend	0	USD
CY2019	wkhs	Value Of Warrants Issued With Preferred Stock ValueOfWarrantsIssuedWithPreferredStock	6709961	USD
CY2019	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	564817	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1979998	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-37162827	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-34913110	USD
CY2020	wkhs	Stock Options And Warrants Exercised And Vesting Of Restricted Shares StockOptionsAndWarrantsExercisedAndVestingOfRestrictedShares	82093632	USD
CY2020	wkhs	Preferred Stock Dividends Common Stock Issued Value PreferredStockDividendsCommonStockIssuedValue	1491860	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	270794684	USD
CY2020	wkhs	Stock Issued During Period Value Interest On Convertible Notes StockIssuedDuringPeriodValueInterestOnConvertibleNotes	1939964	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4020805	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	69776499	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	395204334	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	69776499	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-37162827	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	809645	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	388401	USD
CY2020	wkhs	Tooling Expense ToolingExpense	350500	USD
CY2019	wkhs	Tooling Expense ToolingExpense	0	USD
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6550212	USD
CY2019	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3518356	USD
CY2020	wkhs	Amortization Of Discount On Series Preferred Stock AmortizationOfDiscountOnSeriesPreferredStock	5857092	USD
CY2019	wkhs	Amortization Of Discount On Series Preferred Stock AmortizationOfDiscountOnSeriesPreferredStock	852869	USD
CY2020	wkhs	Change In Fair Value Convertible Notes ChangeInFairValueConvertibleNotes	-160749118	USD
CY2019	wkhs	Change In Fair Value Convertible Notes ChangeInFairValueConvertibleNotes	-1064817	USD
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	12176690	USD
CY2019	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	15369253	USD
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	318361944	USD
CY2019	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	0	USD
CY2020	wkhs	Payments For Preferred Stock Dividends Noncash PaymentsForPreferredStockDividendsNoncash	-1491860	USD
CY2019	wkhs	Payments For Preferred Stock Dividends Noncash PaymentsForPreferredStockDividendsNoncash	-1166771	USD
CY2020	wkhs	Interest On Convertible Note Paid In Common Stock InterestOnConvertibleNotePaidInCommonStock	1939964	USD
CY2019	wkhs	Interest On Convertible Note Paid In Common Stock InterestOnConvertibleNotePaidInCommonStock	0	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	4020805	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1979998	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019	us-gaap	Inventory Write Down InventoryWriteDown	694448	USD
CY2020	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
CY2019	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	3655000	USD
CY2020	wkhs	Investment Received On Sale Of Intellectual Property InvestmentReceivedOnSaleOfIntellectualProperty	0	USD
CY2019	wkhs	Investment Received On Sale Of Intellectual Property InvestmentReceivedOnSaleOfIntellectualProperty	12194800	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-19367	USD
CY2020	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	961966	USD
CY2019	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-76163	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13668866	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-41022	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	27947128	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4367928	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5499464	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3605682	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	207040	USD
CY2020	wkhs	Increase Decrease In Warranty IncreaseDecreaseInWarranty	601864	USD
CY2019	wkhs	Increase Decrease In Warranty IncreaseDecreaseInWarranty	1056905	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-21833930	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-70278949	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-36871677	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5728130	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2005498	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	3655000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5728130	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1654502	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	5854140	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5854140	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	216360651	USD
CY2020	wkhs	Redemption Of Proceeds From Issuance Of Series B Preferred Stock RedemptionOfProceedsFromIssuanceOfSeriesBPreferredStock	-25000000	USD
CY2019	wkhs	Redemption Of Proceeds From Issuance Of Series B Preferred Stock RedemptionOfProceedsFromIssuanceOfSeriesBPreferredStock	25000000	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	262374788	USD
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	38950000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1340700	USD
CY2020	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	1411000	USD
CY2019	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10000000	USD
CY2020	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
CY2019	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5928235	USD
CY2020	wkhs	Exercise Of Warrants And Options ExerciseOfWarrantsAndOptions	53581942	USD
CY2019	wkhs	Exercise Of Warrants And Options ExerciseOfWarrantsAndOptions	35306	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	292367730	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	58572841	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	23355666	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24868416	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1512750	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	241229067	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24868416	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	12700000	USD
CY2020	wkhs	Interest Paid Convertible Notes InterestPaidConvertibleNotes	7600000	USD
CY2020Q3	wkhs	Interest Paid Redemption Of Preferred Stock InterestPaidRedemptionOfPreferredStock	-4700000	USD
CY2020	wkhs	Interest Paid Financing Fees InterestPaidFinancingFees	400000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	7200000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46817825	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	46817825	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23868416	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	194411242	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	241229067	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24868416	USD
CY2020	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	19600000	shares
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	270800000	USD
CY2019	wkhs	Warrants To Purchase Of Common Stock Shares WarrantsToPurchaseOfCommonStockShares	6700000	shares
CY2020	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassifications</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to the prior year consolidated financial statements to conform to the current year presentation. These reclassifications had no effect on previously reported results of operations or stockholders’ equity.</span></div>
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2537353	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	954225	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1711111	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	112750	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	1412500	USD
CY2019Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	1412500	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	334338	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	928709	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5995302	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3408184	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6001864	USD
CY2018Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	7058769	USD
CY2020	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	2115762	USD
CY2019	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	92191	USD
CY2020	wkhs	Standard Product Warranty Accrual Costs Incurred StandardProductWarrantyAccrualCostsIncurred	-2717626	USD
CY2019	wkhs	Standard Product Warranty Accrual Costs Incurred StandardProductWarrantyAccrualCostsIncurred	-1149096	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	5400000	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	6001864	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-37162827	USD
CY2020	us-gaap	Dividends Dividends	0	USD
CY2019	us-gaap	Dividends Dividends	86207	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	69776499	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-37249034	USD
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92871936	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92871936	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64314756	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99949868	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64314756	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1041531	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	36021502	shares
CY2020	wkhs	Fair Value Assumption Expected Volatility Rate FairValueAssumptionExpectedVolatilityRate	0.50
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses for the periods presented. Significant estimates and assumptions are used for, but are not limited to warranty liability, warrant liability, fair value of the convertible notes and litigation-related accruals. Actual results could differ from our estimates.</span></div>
CY2020Q4	wkhs	Production Employees That Tested Positive For Covid19 Percentage ProductionEmployeesThatTestedPositiveForCOVID19Percentage	0.40
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	16759232	USD
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	3741097	USD
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	422176	USD
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	422176	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	277419	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	USD
CY2020Q4	us-gaap	Inventory Gross InventoryGross	17458827	USD
CY2019Q4	us-gaap	Inventory Gross InventoryGross	4163273	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1991815	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2365127	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	15467012	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	1798146	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	21800000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1392519	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	376562	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14857115	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9479485	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3458949	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2649304	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11398166	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6830181	USD
CY2020	us-gaap	Depreciation Depreciation	800000	USD
CY2019	us-gaap	Depreciation Depreciation	400000	USD
CY2019Q2	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P7Y
CY2020	wkhs	Common Stock Issued For Payment Of Series B Preferred Stock Dividend CommonStockIssuedForPaymentOfSeriesBPreferredStockDividend	900000	shares
CY2019	wkhs	Common Stock Issued For Payment Of Series B Preferred Stock Dividend CommonStockIssuedForPaymentOfSeriesBPreferredStockDividend	700000	shares
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	21864569	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-30639	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	21833930	USD
CY2019	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21833930	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.001
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.006
CY2020	wkhs	Effective Income Tax Rate Reconciliation Fair Value Adjustments On Warrant Liability Percent EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsOnWarrantLiabilityPercent	0.371
CY2019	wkhs	Effective Income Tax Rate Reconciliation Fair Value Adjustments On Warrant Liability Percent EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsOnWarrantLiabilityPercent	-0.093
CY2020	wkhs	Effective Income Tax Rate Reconciliation Fair Value Adjustments On Convertible Notes Percent EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsOnConvertibleNotesPercent	0.028
CY2019	wkhs	Effective Income Tax Rate Reconciliation Fair Value Adjustments On Convertible Notes Percent EffectiveIncomeTaxRateReconciliationFairValueAdjustmentsOnConvertibleNotesPercent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.066
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Other EffectiveIncomeTaxRateReconciliationTaxCreditsOther	0.008
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.304
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.103
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.238
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-27800000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	853199	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	802526	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	1150830	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	1275047	USD
CY2020Q4	wkhs	Deferred Tax Assets Non Qualified Stock Options DeferredTaxAssetsNonQualifiedStockOptions	358808	USD
CY2019Q4	wkhs	Deferred Tax Assets Non Qualified Stock Options DeferredTaxAssetsNonQualifiedStockOptions	961919	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	319632	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	202755	USD
CY2020Q4	wkhs	Deferred Tax Liability Fair Value Adjustment Of Investment DeferredTaxLiabilityFairValueAdjustmentOfInvestment	66674379	USD
CY2019Q4	wkhs	Deferred Tax Liability Fair Value Adjustment Of Investment DeferredTaxLiabilityFairValueAdjustmentOfInvestment	0	USD
CY2020Q4	wkhs	Deferred Tax Assets Loan Issuance Fees DeferredTaxAssetsLoanIssuanceFees	1031658	USD
CY2019Q4	wkhs	Deferred Tax Assets Loan Issuance Fees DeferredTaxAssetsLoanIssuanceFees	0	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	0	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	88200	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	47344755	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	30213192	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	16254761	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	33367239	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5579169	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33367239	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	21833930	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1163282	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1163282	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1163282	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1163282	USD
CY2019	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2020	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4020805	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1979998	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y6M
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1972740	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.1
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y9M18D
CY2019	wkhs	Number Of Warrants Granted Series B Preferred Stock NumberOfWarrantsGrantedSeriesBPreferredStock	9262500	shares
CY2019	wkhs	Weighted Average Exercise Price Per Warrant Granted Series B Preferred Stock WeightedAverageExercisePricePerWarrantGrantedSeriesBPreferredStock	1.62

Files In Submission

Name	View Source	Status
0001628280-21-003538-index-headers.html	Edgar Link	pending
0001628280-21-003538-index.html	Edgar Link	pending
0001628280-21-003538.txt	Edgar Link	pending
0001628280-21-003538-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wkhs-20201231.htm	Edgar Link	pending
wkhs-20201231.xsd	Edgar Link	pending
wkhs-20201231x10kxex108.htm	Edgar Link	pending
wkhs-20201231x10kxex231.htm	Edgar Link	pending
wkhs-20201231x10kxex311.htm	Edgar Link	pending
wkhs-20201231x10kxex312.htm	Edgar Link	pending
wkhs-20201231x10kxex321.htm	Edgar Link	pending
wkhs-20201231x10kxex322.htm	Edgar Link	pending
wkhs-20201231x10kxex412.htm	Edgar Link	pending
wkhs-20201231_cal.xml	Edgar Link	unprocessable
wkhs-20201231_def.xml	Edgar Link	unprocessable
wkhs-20201231_g1.jpg	Edgar Link	pending
wkhs-20201231_g2.jpg	Edgar Link	pending
wkhs-20201231_g3.jpg	Edgar Link	pending
wkhs-20201231_htm.xml	Edgar Link	completed
wkhs-20201231_lab.xml	Edgar Link	unprocessable
wkhs-20201231_pre.xml	Edgar Link	unprocessable
wkhs-2020x10xkxex211.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WKHS
Workhorse Group Inc. Stock $wkhs

2020 Form 10-K Financial Statement

#000162828021003538 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKHS Workhorse Group Inc. Stock $wkhs

2020 Form 10-K Financial Statement

#000162828021003538 Filed on March 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WKHS
Workhorse Group Inc. Stock $wkhs